Simulations Plus IncNASDAQ:SLP
- LAST PRICE27.4900
- TODAY'S CHANGE (%)-0.2900 (-1.0439%)
- Bid / Lots27.4600/ 8
- Ask / Lots27.5000/ 8
- Open / Previous Close27.9500 / 27.7800
- Day Range
- 52 Week Range
- Volume106,491
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SLP |
|---|---|---|
| 09:32 ET | 2868 | 27.95 |
| 09:35 ET | 100 | 27.78 |
| 09:39 ET | 200 | 27.71 |
| 09:42 ET | 100 | 27.68 |
| 09:44 ET | 100 | 27.735 |
| 09:48 ET | 1119 | 27.73 |
| 09:50 ET | 100 | 27.73 |
| 09:51 ET | 100 | 27.68 |
| 09:53 ET | 121 | 27.765 |
| 09:57 ET | 100 | 27.7 |
| 10:00 ET | 796 | 27.77 |
| 10:02 ET | 200 | 27.86 |
| 10:06 ET | 1693 | 28 |
| 10:08 ET | 400 | 28.08 |
| 10:15 ET | 100 | 28.055 |
| 10:20 ET | 100 | 28.065 |
| 10:26 ET | 300 | 28.14 |
| 10:27 ET | 100 | 28.18 |
| 10:31 ET | 100 | 28.24 |
| 10:38 ET | 100 | 28.31 |
| 10:42 ET | 100 | 28.425 |
| 10:44 ET | 1800 | 28.39 |
| 10:45 ET | 1200 | 28.53 |
| 10:47 ET | 100 | 28.6 |
| 11:00 ET | 1250 | 28.42 |
| 11:02 ET | 200 | 28.47 |
| 11:03 ET | 411 | 28.33 |
| 11:05 ET | 500 | 28.275 |
| 11:07 ET | 1501 | 28.19 |
| 11:12 ET | 100 | 28.2 |
| 11:14 ET | 200 | 28.13 |
| 11:20 ET | 1020 | 28.01 |
| 11:32 ET | 687 | 27.94 |
| 11:41 ET | 200 | 27.89 |
| 11:45 ET | 100 | 27.88 |
| 11:48 ET | 100 | 27.87 |
| 11:50 ET | 150 | 27.8819 |
| 11:52 ET | 200 | 27.87 |
| 11:56 ET | 406 | 27.78 |
| 11:57 ET | 1475 | 27.83 |
| 11:59 ET | 100 | 27.8 |
| 12:01 ET | 260 | 27.78 |
| 12:03 ET | 1034 | 27.81 |
| 12:06 ET | 200 | 27.795 |
| 12:10 ET | 100 | 27.76 |
| 12:12 ET | 799 | 27.85 |
| 12:15 ET | 100 | 27.825 |
| 12:19 ET | 208 | 27.82 |
| 12:24 ET | 300 | 27.85 |
| 12:26 ET | 100 | 27.885 |
| 12:28 ET | 100 | 27.915 |
| 12:32 ET | 100 | 27.92 |
| 12:33 ET | 100 | 27.945 |
| 12:35 ET | 200 | 27.94 |
| 12:46 ET | 200 | 27.89 |
| 12:48 ET | 150 | 27.9099 |
| 12:51 ET | 600 | 27.9291 |
| 12:53 ET | 150 | 27.9236 |
| 12:55 ET | 200 | 27.935 |
| 01:00 ET | 847 | 27.97 |
| 01:02 ET | 278 | 28.02 |
| 01:04 ET | 420 | 27.95 |
| 01:09 ET | 1371 | 27.91 |
| 01:11 ET | 100 | 27.91 |
| 01:15 ET | 300 | 27.97 |
| 01:18 ET | 1328 | 27.955 |
| 01:26 ET | 200 | 27.98 |
| 01:27 ET | 100 | 27.955 |
| 01:29 ET | 700 | 27.99 |
| 01:33 ET | 400 | 28.01 |
| 01:38 ET | 725 | 28.0775 |
| 01:40 ET | 100 | 28.08 |
| 01:44 ET | 255 | 28.0661 |
| 01:45 ET | 100 | 28.04 |
| 01:51 ET | 160 | 28.045 |
| 01:54 ET | 100 | 28.045 |
| 01:56 ET | 392 | 28 |
| 02:00 ET | 300 | 27.99 |
| 02:03 ET | 300 | 27.9 |
| 02:05 ET | 200 | 27.89 |
| 02:09 ET | 467 | 27.83 |
| 02:12 ET | 100 | 27.82 |
| 02:18 ET | 200 | 27.78 |
| 02:21 ET | 320 | 27.75 |
| 02:23 ET | 1301 | 27.73 |
| 02:27 ET | 200 | 27.765 |
| 02:30 ET | 100 | 27.74 |
| 02:32 ET | 100 | 27.71 |
| 02:34 ET | 200 | 27.71 |
| 02:38 ET | 100 | 27.71 |
| 02:39 ET | 100 | 27.71 |
| 02:41 ET | 100 | 27.7 |
| 02:43 ET | 100 | 27.7 |
| 02:48 ET | 1199 | 27.69 |
| 02:50 ET | 100 | 27.675 |
| 02:54 ET | 100 | 27.66 |
| 02:56 ET | 300 | 27.66 |
| 02:57 ET | 500 | 27.68 |
| 02:59 ET | 200 | 27.685 |
| 03:01 ET | 786 | 27.7 |
| 03:08 ET | 100 | 27.765 |
| 03:10 ET | 500 | 27.72 |
| 03:12 ET | 100 | 27.745 |
| 03:15 ET | 104 | 27.742 |
| 03:17 ET | 992 | 27.7 |
| 03:21 ET | 100 | 27.66 |
| 03:24 ET | 1331 | 27.63 |
| 03:26 ET | 1000 | 27.63 |
| 03:28 ET | 100 | 27.6 |
| 03:30 ET | 800 | 27.63 |
| 03:32 ET | 100 | 27.625 |
| 03:33 ET | 2136 | 27.61 |
| 03:35 ET | 120 | 27.5993 |
| 03:37 ET | 1017 | 27.51 |
| 03:39 ET | 100 | 27.47 |
| 03:42 ET | 1257 | 27.5 |
| 03:44 ET | 1000 | 27.55 |
| 03:46 ET | 200 | 27.51 |
| 03:48 ET | 876 | 27.51 |
| 03:50 ET | 400 | 27.52 |
| 03:51 ET | 2014 | 27.5652 |
| 03:53 ET | 1823 | 27.565 |
| 03:55 ET | 2100 | 27.53 |
| 03:57 ET | 3252 | 27.49 |
Oct 30, 2024
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations, from 8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
8:30AM ET on Wednesday Oct 30, 2024 by Dow Jones
Oct 24, 2024
DJ Simulations Plus Is Maintained at Buy by BTIG, from 12:26PM ET on Thursday Oct 24, 2024 by Dow Jones
12:26PM ET on Thursday Oct 24, 2024 by Dow Jones
Oct 23, 2024
*DJ Simulations Plus 4Q EPS 4c >SLP, from 4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones
4:06PM ET on Wednesday Oct 23, 2024 by Dow JonesSimulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results, from 4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones
4:06PM ET on Wednesday Oct 23, 2024 by Dow Jones
Oct 9, 2024
Press Release: Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date, from 5:49PM ET on Wednesday Oct 09, 2024 by Dow Jones
5:49PM ET on Wednesday Oct 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Simulations Plus Inc | 555.8M | 58.0x | +3.18% |
IRadimed Corp | 612.0M | 33.7x | +21.02% |
Butterfly Network Inc | 431.5M | -3.9x | --- |
MaxCyte Inc | 397.0M | -11.0x | --- |
Electromed Inc | 192.5M | 39.6x | +20.42% |
Neuropace Inc | 183.6M | -5.8x | --- |
Company Information
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. The Company also provides tech-enabled training and compliance solutions for clinical trial investigators and site staff.
Contact Information
- Headquarters
- 42505 10Th Street WestLANCASTER, CA, United States 93534-7059
- Phone
- 661-723-7723
- Fax
- 661-723-5524
Executives
- Chairman of the Board
- Walter Woltosz
- Chief Executive Officer
- Shawn O'Connor
- Chief Financial Officer, Chief Operating Officer, Secretary
- William Frederick
- President - PBPK, Regulatory Strategies, Cheminformatics Solutions
- John Dibella
- President - Clinical Pharmacology and Pharmacometric Services
- Jill Fiedler-Kelly
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $555.8M |
|---|---|
Revenue (TTM) | $67.0M |
Shares Outstanding | 20.0M |
Dividend Yield | 0.87% |
Annual Dividend Rate | 0.2400 USD |
Ex-Dividend Date | 07-29-24 |
Pay Date | 08-05-24 |
Beta | 0.72 |
EPS | $0.47 |
Book Value | $8.53 |
P/E Ratio | 58.0x |
Price/Sales (TTM) | 8.3 |
Price/Cash Flow (TTM) | 39.3x |
Operating Margin | 9.83% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
